Effects of loperamide on anal sphincter function in patients complaining of chronic diarrhea with fecal incontinence and urgency

• Published in: Digestive diseases and sciences Vol. 27; no. 9; p. 807
• Main Authors: Read, M, Read, N W, Barber, D C, Duthie, H L
• Format: Journal Article
• Language: English
• Published: United States 01.09.1982
• Subjects: Adult; Aged; Anal Canal - drug effects; Anal Canal - physiopathology; Diarrhea - drug therapy; Diarrhea - physiopathology; Fecal Incontinence - drug therapy; Fecal Incontinence - physiopathology; Female; Humans; Loperamide - pharmacology; Loperamide - therapeutic use; Male; Manometry; Middle Aged; Piperidines - pharmacology; Rectum - drug effects
• ISSN: 0163-2116
• DOI: 10.1007/BF01391374

We have investigated the effect of loperamide (4 mg tds) on the continence to a standard volume of rectally infused saline and anorectal manometry in 26 patients complaining of chronic diarrhea complicated by fecal incontinence and severe urgency. Each patient was treated for one week with loperamide (4 mg tds) and for one week with an identical placebo in a double-blind cross-over trial. Our results showed that as well as its established effects of improving stool consistency and reducing stool weight, frequency and episodes of incontinence and severe urgency, loperamide also significantly improved continence to a standard volume of rectally infused saline. This action was associated with an increase in the maximum basal sphincter pressure, an increase in the rectal volume required to abolish recovery of the rectoanal inhibitory reflex, and a reduction in rectal compliance. These results suggest that loperamide may have a specific action on the anal sphincter, which may aid continence in patients who complain of diarrhea and fecal incontinence.